Key Metrics 
Check Before You Invest 
10 Yrs X-Ray 
Valuation 
Analyst Note 
Qtr. Results 
Financials 
News 
About
Source Natural Foods and Herbal Supplements Ltd (531398)
Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 531398 NSE: Pharmaceuticals & Drugs | Small Cap | Source Natural Foods Share Price
₹108.95 0.20 (0.18%)
As on 25-Sep'26 16:59
Source Natural Foods and Herbal Supplements Ltd (531398)
Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 531398 NSE: Pharmaceuticals & Drugs | Small Cap | Source Natural Foods Share Price
₹108.95 0.20 (0.18%)
As on 25-Sep'26 16:59
Key Metrics
Valuation Multiples
Market Cap
₹70 Cr.
Current Price
₹109
52-Week Low / High
₹97 / 170
TTM EPS
-
TTM Sales
-
Book Value per Share
-
P/E Ratio
Industry PE
54.9
Price to Book (P/B)
Price to Sales (P/S)
EV/EBITDA
Dividend Yield
0%
Profitability Efficiency
Return on Equity (ROE)
%
Return on Capital Employed (ROCE)
%
Return on Assets (ROA)
%
Operating Profit Margin
0%
Net Profit Margin
-%
Gross Profit Margin
0%
Growth Momentum
1-yr vs 3-yr growth
1-yr vs 3-yr growth
Sales Growth (1 Year)
Improving versus 3-year growth rate
64.54%
Operating Profit Growth (1 Year)
-
-
Net Profit Growth (1 Year)
-
-
Asset Quality
Promoter Holding
74.37%
Pledged shares (%) of Promoter's holding (%)
0.00%
Reserves
-
Equity
₹6.4 Cr.
Face Value
₹10
All Time Low / High
₹1.00 / 269.75
Check Before You Invest
M-Cap below 100cr DeciZen not available
Is Source Natural Foods and Herbal Supplements Ltd a good quality company?
Source Natural Foods and Herbal Supplements Ltd is a quality company, based on a multi-year financial track record.
This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.
We have analysed the performance of the company on the following:
-
How has it performed on generating Profits?
By checking its Revenue growth, Gross, Operating and Net Margins compared to its last 5-year median.
-
How efficiently has it utilized Capital?
By checking its ROCE, ROA, ROE and its Cash Conversion Cycle.
-
How is it managing its Debt?
By checking its Debt to Equity and Cash Flow from Operations.
How does Source Natural Foods and Herbal Supplements Ltd performance compare with that of its Peers?
Revenue growth of Source Natural Foods and Herbal Supplements Ltd vs industry peers?
Source Natural Foods and Herbal Supplements Ltd revenue CAGR is %, compared to the industry median CAGR of 0%, indicating stable growth and maintaining its market share.
Promoter shareholding and pledge status of Source Natural Foods and Herbal Supplements Ltd?
Promoters hold 74.37% of the Source Natural Foods and Herbal Supplements Ltd, with 0.00% of their stake pledged, indicating no pledge risk.
Stock return of Source Natural Foods and Herbal Supplements Ltd over the last decade?
Over the last 9 year(s), the stock has delivered a CAGR of 11.1% based on the current price.
10 Year X-Ray :
Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year endData adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.
What is a Financial Track Record? How to read this chart in order to understand the data present here?
Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Source Natural Foods and Herbal Supplements Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good
Value Creation ⓘ
| Mar'16 | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROCE % ⓘ | 8.9% | 20.4% | 11.7% | 13.6% | 20.9% | 33.1% | 26.4% | 18% | 17.6% | 16.7% | - |
| Value Creation Index ⓘ | -0.4 | 0.5 | -0.2 | 0.0 | 0.5 | 1.4 | 0.9 | 0.3 | 0.3 | 0.2 | - |
Growth Parameters ⓘ |
|||||||||||
| Sales ⓘ | 10.9 | 15.9 | 10.8 | 12.8 | 13.6 | 24.9 | 21.5 | 19.8 | 27.3 | 44.9 | 80 |
| Sales YoY Gr. | - | 45.8% | -32% | 18.2% | 6.1% | 83.1% | -13.5% | -8.1% | 38% | 64.5% | - |
| Adj EPS ⓘ | 0.7 | 2.2 | 1.2 | 1.6 | 2.6 | 5.3 | 3.8 | 3.3 | 2.8 | 4.5 | 5.5 |
| YoY Gr. | - | 230.3% | -43.1% | 28.2% | 60.4% | 106.3% | -28.1% | -12.7% | -16.7% | 64% | - |
| BVPS (₹) ⓘ | 8.6 | 10.8 | 12.1 | 13.7 | 15.2 | 20.5 | 24.2 | 27.5 | 30.2 | 34.7 | 41.2 |
| Adj Net Profit ⓘ | 0.4 | 1.4 | 0.8 | 1 | 1.6 | 3.4 | 2.4 | 2.1 | 1.8 | 2.9 | 4 |
| Cash Flow from Ops. ⓘ | 0.4 | -0.7 | 0.1 | 2.6 | -0.4 | 4.5 | -0.7 | 2.5 | 2.7 | 0.1 | - |
| Debt/CF from Ops. ⓘ | 0.2 | -2.8 | 16.4 | 0.1 | -3.1 | 0.2 | -0.1 | 0 | 0.5 | 113.1 | - |
CAGR ⓘ
| 9 Years | 5 Years | 3 Years | 1 Years | |||||
|---|---|---|---|---|---|---|---|---|
| Sales ⓘ | 17% | 27% | 27.8% | 64.5% | ||||
| Adj EPS ⓘ | 23.8% | 12.1% | 6.1% | 64% | ||||
| BVPSⓘ | 16.7% | 18% | 12.8% | 14.9% | ||||
| Share Price | 11.1% | -5.2% | 6.7% | -19.7% | ||||
Key Financial Parameters ⓘ
| Mar'16 | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Return on Equity % ⓘ | 8 | 22.4 | 10.9 | 12.4 | 17.7 | 29.5 | 16.9 | 12.7 | 9.5 | 13.9 | 14.4 |
| Op. Profit Mgn % ⓘ | 8.8 | 11.5 | 13 | 12.4 | 17.6 | 16.8 | 17.9 | 18.2 | 16.4 | 11.5 | 7.9 |
| Net Profit Mgn % ⓘ | 3.9 | 8.8 | 7.4 | 8 | 12.1 | 13.6 | 11.3 | 10.7 | 6.5 | 6.5 | 4.4 |
| Debt to Equity ⓘ | 0 | 0.3 | 0.2 | 0 | 0.1 | 0.1 | 0 | 0 | 0.1 | 0.3 | - |
| Working Cap Days ⓘ | 67 | 105 | 242 | 166 | 179 | 130 | 184 | 230 | 149 | 133 | 75 |
| Cash Conv. Cycle ⓘ | 30 | 58 | 172 | 132 | 138 | 103 | 132 | 160 | 103 | 82 | 38 |
Valuation of Source Natural Foods - Consolidated
Analyst's Notes
No data found!
Management X-Ray
Shareholding Pattern
Promoter's Holding & Share Pledging
| Pledged * | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
* Pledged shares as % of Promoter's holding (%)
Financials
No data found!
No data found!
No data found!
No data found!
Top 5 Mutual Funds Holding
Last Visited Stocks
Announcements
Source Natural Foods and Herbal Supplements Ltd FAQs
The current trading price of Source Natural Foods on 25-Sep-2026 16:59 is ₹109.0.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 24-Sep-2026 the market cap of Source Natural Foods stood at ₹70.13 Cr
The latest P/E ratio of Source Natural Foods as of 24-Sep-2026 is 19.99.
The latest P/B ratio of Source Natural Foods as of 24-Sep-2026 is 2.65.
The 52-week high of Source Natural Foods is ₹170.0 and the 52-week low is ₹96.55.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Source Natural Foods is ₹79.70 ( Cr.) .
Past 10 year’s financial track record analysis by Moneyworks4me indicates that Source Natural Foods and Herbal Supplements Ltd is a below average quality company.
The key valuation ratios of Source Natural Foods and Herbal Supplements Ltd's currently when compared to its past seem to suggest it is in the Undervalued zone.
The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Source Natural Foods and Herbal Supplements Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.
About Source Natural Foods and Herbal Supplements Ltd
Inwinex Pharmaceuticals, incorporated in 1995, is engaged in the manufacture of pharmaceuticals. Earlier known as Inwinex Laboratories, it got its present name on March 2, 2007.
The company has been incurring losses for past couple of years on account of partial shutdown of the factory for renovation and inadequate working capital facilities. The factory, located at Hyderabad in Andhra Pradesh, has been completely shut down since April 12, 2006 due to inadequacy of working capital.
In 2000, company decided to hive-off the bulk drug unit and diversify into software related activities by changing the main clause. And in 2001, the company has signed an agreement with CDSL, NSDL and Venture Capital and Corporate Investment for dematerialization.
Business areas of the company:
The company manufactures antibiotics, norfloxacin, pefloxacin, enrofloxacin and electrolyte supplements.
You have 45 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
